News
October 1, 2021
Nearly half of the participants (49%) had plaque in their arteries. ACTG Read the full article here.
October 1, 2021
Researchers ID condition with potential CVD implications. Randy YoungMGH News and Public Affairs Read the full article from HMS here.
September 3, 2020
The REPRIEVE study, which is primarily looking at a statin’s effect on cardiovascular disease, is shedding light on many other mysteries. Benjamin RyanEditor at Large, POZ […]
September 3, 2020
Initial data from a large NIH-supported clinical trial offer a detailed look at the health status of people aging with HIV around the world. With 7,770 […]
July 22, 2020
The suite of manuscripts, utilizing key baseline data from the REPRIEVE trial, highlight the impact and prevalence of critical comorbidities among a global cohort of people […]
July 22, 2020
The impact and prevalence of heart disease and other critical comorbidities on an aging global population with human immunodeficiency virus (HIV) have emerged from a suite […]
October 5, 2018
People living with HIV are developing heart disease at twice the rate of the general population, and Prism Health and Harvard Medical School want to know […]
September 10, 2018
An international clinical trial, which is looking for effective ways to prevent heart disease in those living with HIV, has hit 7,000 participants. “It’s a major […]
May 7, 2018
HIV-related heart disease is a leading cause of death among people living with HIV — even when they are on consistent, effective HIV treatment. Researchers are […]